Comparison of PanBio dengue IgM ELISA assay with pentax dengue IgM particle agglutination assay to evaluate factors affecting false positive results.
The objectives of this study were to conduct a further evaluation of performance characteristics (sensitivity/specificity, predictive values, cross-reactivity) of PanBio Dengue IgM (IgM-EIA test), particularly during non-epidemic periods in New Caledonia, and (ii) to evaluate an alternative test, Pentax Dengue IgM-Particle Agglutination (PA-lgM) test. A total of 1,808 samples were first tested with the IgM-EIA test and reactive specimens were then re-tested with IgM-PA test. Sensitivity and specificity were measured on a prospective mode from 2005 and 2006. Other etiologies were also investigated to confirm the non-specific reactive results. One hundred fifty-three samples were initially reactive with IgM-EIA test. Of these, 147 were classified as non specific and only 16 were reactive with the particle agglutination test (89.1% reduction of this interference). The specificity and positive predictive value of the ELISA test was 91.8% and 5.8%, respectively. The extrapolated specificity and positive predictive value for the particle agglutination test was 99.1% and 33.3%, respectively. Hepatitis A was identified as a major source of false positive, followed by rheumatoid factor and leptospirosis. Sensitivity of both tests was100% on samples taken from the fifth day of the disease.
Institut Pasteur de Nouvelle-Calédonie, Nouméa, New Caledonia. aberlioz@pasteur.nc
Alain
A
Berlioz-Arthaud
Albert
A
Gurusamy
D000372:Agglutination Tests; D000918:Antibody Specificity; D003715:Dengue / Q000175:diagnosis* / Q000276:immunology; D003716:Dengue Virus / Q000302:isolation & purification*; D003937:Diagnosis, Differential; D004797:Enzyme-Linked Immunosorbent Assay; D005189:False Positive Reactions; D006801:Humans; D007075:Immunoglobulin M / Q000032:analysis*; D009510:New Caledonia; D012680:Sensitivity and Specificity
D007075:Immunoglobulin M